Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.
Ayami KanekoNobuaki KobayashKenji MiuraHiromi MatsumotoKohei SomekawaTomofumi HiroseYukihito KajitaAnna TanakaShuhei TeranishiYu SairenjiHidetoshi KawashimaKentaro YumotoToshinori TsukaharaNobuhiko FukudaRyuichi NishihiraKeisuke WatanabeNobuyuki HoritaYu HaraMakoto KudoNaoki MiyazawaTakeshi KanekoPublished in: Thoracic cancer (2024)
In real-world practice, CP demonstrated superior PFS compared with CNI. These findings can inform treatment selection in advanced NSCLC.